:vemurafenib:

Ersin Bozan1, Tahir Darçın2, Samet Yaman2

  • 1Department of Hematology and Bone Marrow Transplantation Center, Hematology and Bone Marrow Transplantation Unit, Health Sciences University Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital, Ankara, Turkey. ersinbozan87@gmail.com.

PubMed
概括

埃尔德海姆切斯特病 (ECD) 是一种罕见的多系统性疾病,通过向治疗有效治疗. 这一案例突显了BRAF V600E在ECD中的突变向治疗的显著反应.